Bittensor subnet Metanova uses competition-driven AI drug discovery with robot labs
const_reborn · x · 2026-10-11
Metanova Labs (subnet SN68 on Bittensor) describes its approach to AI drug discovery: harnessing competition to identify entry points in multibillion-dollar therapeutic spaces, and accelerating learning cycles via labs-in-the-loop robotics partnerships.
Early backer @haitzu called Metanova one of Bittensor's most important subnets, leveraging collective intelligence to generate new drug candidates.
More from Research
- ML interatomic potentials reveal fast Li+ conduction mechanism in glassy antiperovskites — TimothyDuignan · 2026-10-11
- Lean4 proofs are not a silver bullet: consistency gaps, soundness bugs, and flawed benchmarks — elie · 2026-10-11
- Training inside the harness lifts Qwen3-14B from 22.2% to 54.8% on Spider 2.0-SQLite — omarsar0 · 2026-10-11
- REMAG brings GPU-first SIESTA to magnetic materials with up to 111x speedups — CatAstro_Piyush · 2026-10-11
- Yoav Goldberg blasts COLM mood: RL loss tweaks aren't 'science again' — yoavgo · 2026-10-11
- Stanford paper: fix looping agents via harness edits, bad plans need weight training — rohanpaul_ai · 2026-10-11